Exhibit 107
Calculation of Filing Fee Tables
Form S-3
(Form Type)
Acrivon Therapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
| Security Type |
Security Class Title |
Fee Calculation Rule |
Amount Registered(1) |
Proposed Maximum Offering Price Per Unit(2) |
Maximum Price(2) |
Fee Rate |
Amount of Registration Fee |
Carry Form |
Carry Forward File Number |
Carry Forward Initial effective date |
Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward | |||||||||||||
| Newly Registered Securities | ||||||||||||||||||||||||
| Fees to be Paid |
Equity | Common Stock, par value $0.001 per share | 457(c) | 15,295,000 | $9.75 | $149,126,250 | 0.0001476 | $22,011.04 | ||||||||||||||||
| Fees Previously Paid |
— | — | — | — | — | — | — | |||||||||||||||||
| Carry Forward Securities | ||||||||||||||||||||||||
| Carry Forward Securities |
— | — | — | — | — | — | — | — | — | |||||||||||||||
| Total Offering Amounts | $149,126,250 | $22,011.04 | ||||||||||||||||||||||
| Total Fees Previously Paid | $0.00 | |||||||||||||||||||||||
| Total Fee Offsets | $0.00 | |||||||||||||||||||||||
| Net Fee Due | $22,011.04 | |||||||||||||||||||||||
| (1) | In addition, pursuant to Rule 416 under the Securities Act of 1933, as amended, the securities registered hereunder include such indeterminate number of securities as may be issuable with respect to the securities being registered hereunder as a result of share splits, share dividends or similar transactions. |
| (2) | Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(c) under the Securities Act of 1933, as amended. The offering price per share and aggregate offering price are based upon the average of the high and low prices for the Registrant’s Common Stock as reported on the Nasdaq Global Market on April 11, 2024, a date within five business days prior to the filing of this Registration Statement. |